In 2025, Roche’s major revenue-generating drug was the **** drug **. Roche is one of the leading pharmaceutical companies globally. They have a variety of products and medications sold worldwide, with oncology being a focus area of the company.
Roche is a multinational pharmaceutical company based in Basel, Switzerland. The company has two primary divisions: pharmaceuticals and diagnostics. Roche has experienced exceptional growth in recent years, which can be seen in the increasing value of their sales globally. As well as sales, Roche has experienced significant growth in their research and development (R&D) expenditures. Roche has been named a leader in global pharma in several ways, but has excelled in producing and selling oncologic pharmaceuticals specifically.
Oncology is a branch of medicine that focuses on the diagnosis and treatment of cancer. The number of new cancer drugs under development in the United States is also increasing every year, with significant growth recently. Oncology and diabetes are the top therapy areas in the United States based on drug spending.
Log in or register to access precise data.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Company positioning & scale
Financial scale & structure
Portfolio, segments & geography
R&D, pipeline & innovation
Competitive landscape
Outlook & risk
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
